Woessner RD - Search Results

1

Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells.

Woessner RD, Mattern MR, Mirabelli CK, Johnson RK, Drake FH. Woessner RD, et al. Cell Growth Differ. 1991 Apr;2(4):209-14. Cell Growth Differ. 1991. PMID: 1651102

2

Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content.

Woessner RD, Eng WK, Hofmann GA, Rieman DJ, McCabe FL, Hertzberg RP, Mattern MR, Tan KB, Johnson RK. Woessner RD, et al. Oncol Res. 1992;4(11-12):481-8. Oncol Res. 1992. PMID: 1338578

3

Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase II.

Woessner RD, Chung TD, Hofmann GA, Mattern MR, Mirabelli CK, Drake FH, Johnson RK. Woessner RD, et al. Cancer Res. 1990 May 15;50(10):2901-8. Cancer Res. 1990. PMID: 2159365

4

Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content.

Eng WK, McCabe FL, Tan KB, Mattern MR, Hofmann GA, Woessner RD, Hertzberg RP, Johnson RK. Eng WK, et al. Among authors: woessner rd. Mol Pharmacol. 1990 Oct;38(4):471-80. Mol Pharmacol. 1990. PMID: 2172765

5

Inhibition of endothelin-mediated topoisomerase I activation by pertussis toxin.

Nambi P, Wu HL, Woessner RD, Mattern MR. Nambi P, et al. Among authors: woessner rd. FEBS Lett. 1990 Dec 10;276(1-2):17-20. doi: 10.1016/0014-5793(90)80496-6. FEBS Lett. 1990. PMID: 2176162 Free article.

6

Decreased vascular endothelial growth factor expression associated with tumor regression induced by (E)-2'-deoxy-2'-(fluoromethylene)cytidine (MDL 101,731).

Woessner RD, Loudy DE, Wallace CD, Montgomery LR, Cross-Doersen DE, Bush TL, Lewis MT, Prakash N, Bitonti AJ, Wright PS. Woessner RD, et al. Oncol Res. 1997;9(10):543-52. Oncol Res. 1997. PMID: 9507532

7

Inhibition of STAT3 with the Generation 2.5 Antisense Oligonucleotide, AZD9150, Decreases Neuroblastoma Tumorigenicity and Increases Chemosensitivity.

Odate S, Veschi V, Yan S, Lam N, Woessner R, Thiele CJ. Odate S, et al. Clin Cancer Res. 2017 Apr 1;23(7):1771-1784. doi: 10.1158/1078-0432.CCR-16-1317. Epub 2016 Oct 19. Clin Cancer Res. 2017. PMID: 27797972 Free PMC article.

8

STAT3 Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti-PD-L1.

Proia TA, Singh M, Woessner R, Carnevalli L, Bommakanti G, Magiera L, Srinivasan S, Grosskurth S, Collins M, Womack C, Griffin M, Ye M, Cantin S, Russell D, Xie M, Hughes A, Deng N, Mele DA, Fawell S, Barry S, Reimer C, Barrett JC, McCoon P. Proia TA, et al. Clin Cancer Res. 2020 Dec 1;26(23):6335-6349. doi: 10.1158/1078-0432.CCR-20-1066. Epub 2020 Sep 17. Clin Cancer Res. 2020. PMID: 32943458

9

Quantitation of vascular endothelial growth factor mRNA levels in human breast tumors and metastatic lymph nodes.

Wright PS, Loudy DE, Cross-Doersen DE, Montgomery LR, Sprinkle-Cavallo J, Miller JA, Distler CM, Lower EE, Woessner RD. Wright PS, et al. Among authors: woessner rd. Exp Mol Pathol. 1997 Feb;64(1):41-51. doi: 10.1006/exmp.1997.2208. Exp Mol Pathol. 1997. PMID: 9203508

10

Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium.

Woessner RD, Wright PS, Loudy DE, Wallace CD, Montgomery LR, Nestok BR. Woessner RD, et al. Exp Mol Pathol. 1998;65(1):37-52. doi: 10.1006/exmp.1998.2225. Exp Mol Pathol. 1998. PMID: 9613925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page